[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100535428":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":41,"collaborators":20,"id":45,"slug":20,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":46,"sex":52,"minAge":53,"maxAge":20,"enrollmentInfo":54,"targetDuration":20,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":20,"overallStatus":30,"whyStopped":20,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention arm","EXPERIMENTAL","CADe system will be used during withdrawal phase of colonscopy",[13],"Device: ENDO-AID CADe",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","ENDO-AID CADe","ENDO-AID CADe will be used during the withdrawal process of the colonscopy",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Felix Sia","CONTACT","26370428","felixsia@cuhk.edu.hk",[28],{"facility":29,"status":30,"city":31,"state":20,"zip":20,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Prince of Wales Hospital","RECRUITING","Hong Kong",{"type":33,"coordinates":34},"Point",[35,36],114.17469,22.27832,{"lat":36,"lon":35},[39],{"name":40,"role":24,"phone":20,"phoneExt":20,"email":20},"Louis Lau",{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Louis Ho Shing Lau","Assistant Professor","100535428",false,"NCT06251700","Longterm Effectiveness of Artificial Intelligence-assisted Colonoscopy on Adenoma Recurrence","Longterm Effectiveness of Artificial Intelligence-assisted Colonoscopy on Adenoma Recurrence - a Prospective Longitudinal Follow-up of Randomized Controlled Trial","ENDOAID-PRO","Inclusion Criteria:\n\nSubjects are eligible if:\n\n(i) They underwent randomization to receive colonoscopy with\u002Fwithout CADe in ENDOAID-TRAIN study \\[NCT04838951\\]; (ii) They are fit and willing to undergo surveillance colonoscopy at year 3; (iii) Written informed consent obtained.\n\nExclusion Criteria:\n\nSubjects will be excluded from the study if they have any of the followings:\n\n(i) Incomplete colonoscopy during index procedure; (ii) Known residual colorectal neoplasia not removed (except hyperplastic polyps); (iii) Underwent unscheduled interval colonoscopy before year 3; (iv) Contraindications to surveillance colonoscopy at year 3; (v) Advanced comorbid (American Society of Anesthesiologists grade 4 or above); (vi) History of CRC, hereditary polyposis syndrome or inflammatory bowel disease; (vii) History of colectomy at any time point.","ALL","18 Years",{"count":55,"type":56},775,"ESTIMATED","INTERVENTIONAL",[59],"NA","We hypothesize that AI-assisted colonoscopy can reduce post-colonoscopy neoplasia incidence after 3 years, over standard colonoscopy. Moreover, this protective effect may allow surveillance intervals to be lengthened, by modifying long-term outcome of high-risk subgroup.",[62],"Screening Colonscopy","2024-10-27",{"date":65,"type":66},"2024-10-29","ACTUAL",{"date":68,"type":66},"2024-01-24",{"date":70,"type":56},"2027-04-30",{"name":5,"class":6},1]